Purpose There is an urgent need to address how to best provide ophthalmic care for
patients with retinal disease receiving intravitreal injections with anti-vascular endothelial
growth factor agents during the ongoing global COVID-19 pandemic. This article provides
guidance for ophthalmologists on how to deliver the best possible care for patients while
minimizing the risk of infection. Methods The Vision Academy's Steering Committee of
international retinal disease experts convened to discuss key considerations for managing …

Abstract The World Health Organization designated the outbreak of the novel coronavirus,
COVID-19, as a pandemic on March 11, 2020, after its rapid spread to countries throughout
the world. 1 There is a strong need to support the ophthalmic community to help guide
decision-making during these unprecedented times, where infection control is of utmost
concern and disruption to regular clinical practice is highly likely. This is particularly
important for patients with retinal diseases who are receiving intravitreal injections of anti …